Literature DB >> 30488513

Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals.

Issa J Dahabreh1,2,3, Sarah E Robertson1, Eric J Tchetgen4, Elizabeth A Stuart5, Miguel A Hernán3,6,7.   

Abstract

We consider methods for causal inference in randomized trials nested within cohorts of trial-eligible individuals, including those who are not randomized. We show how baseline covariate data from the entire cohort, and treatment and outcome data only from randomized individuals, can be used to identify potential (counterfactual) outcome means and average treatment effects in the target population of all eligible individuals. We review identifiability conditions, propose estimators, and assess the estimators' finite-sample performance in simulation studies. As an illustration, we apply the estimators in a trial nested within a cohort of trial-eligible individuals to compare coronary artery bypass grafting surgery plus medical therapy vs. medical therapy alone for chronic coronary artery disease.
© 2019 The International Biometric Society.

Entities:  

Keywords:  causal inference; clinical trials; double robustness; generalizability; observational studies; transportability

Year:  2019        PMID: 30488513     DOI: 10.1111/biom.13009

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  18 in total

1.  The Epidemiologic Toolbox: Identifying, Honing, and Using the Right Tools for the Job.

Authors:  Catherine R Lesko; Alexander P Keil; Jessie K Edwards
Journal:  Am J Epidemiol       Date:  2020-06-01       Impact factor: 4.897

2.  Effect heterogeneity and variable selection for standardizing causal effects to a target population.

Authors:  Anders Huitfeldt; Sonja A Swanson; Mats J Stensrud; Etsuji Suzuki
Journal:  Eur J Epidemiol       Date:  2019-10-26       Impact factor: 8.082

3.  An outcome model approach to transporting a randomized controlled trial results to a target population.

Authors:  Benjamin A Goldstein; Matthew Phelan; Neha J Pagidipati; Rury R Holman; Michael J Pencina; Elizabeth A Stuart
Journal:  J Am Med Inform Assoc       Date:  2019-05-01       Impact factor: 4.497

4.  Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study.

Authors:  Neel M Butala; Kamil F Faridi; Hector Tamez; Jordan B Strom; Yang Song; Changyu Shen; Eric A Secemsky; Laura Mauri; Dean J Kereiakes; Jeptha P Curtis; C Michael Gibson; Robert W Yeh
Journal:  Circulation       Date:  2021-11-08       Impact factor: 29.690

5.  Causally Interpretable Meta-analysis: Application in Adolescent HIV Prevention.

Authors:  David H Barker; Issa J Dahabreh; Jon A Steingrimsson; Christopher Houck; Geri Donenberg; Ralph DiClemente; Larry K Brown
Journal:  Prev Sci       Date:  2021-07-09

6.  Emulating Target Trials to Improve Causal Inference From Agent-Based Models.

Authors:  Eleanor J Murray; Brandon D L Marshall; Ashley L Buchanan
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

7.  Transportability From Randomized Trials to Clinical Care: On Initial HIV Treatment With Efavirenz and Suicidal Thoughts or Behaviors.

Authors:  Katie R Mollan; Brian W Pence; Steven Xu; Jessie K Edwards; W Christopher Mathews; Conall O'Cleirigh; Heidi M Crane; Ellen F Eaton; Ann C Collier; Ann Marie K Weideman; Daniel Westreich; Stephen R Cole; Camlin Tierney; Angela M Bengtson
Journal:  Am J Epidemiol       Date:  2021-10-01       Impact factor: 4.897

8.  Target validity: Bringing treatment of external validity in line with internal validity.

Authors:  Catherine R Lesko; Benjamin Ackerman; Michael Webster-Clark; Jessie K Edwards
Journal:  Curr Epidemiol Rep       Date:  2020-06-30

9.  Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population.

Authors:  Issa J Dahabreh; Sebastien J-P A Haneuse; James M Robins; Sarah E Robertson; Ashley L Buchanan; Elizabeth A Stuart; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

10.  Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control.

Authors:  Sridharan Raghavan; Kevin Josey; Gideon Bahn; Domenic Reda; Sanjay Basu; Seth A Berkowitz; Nicholas Emanuele; Peter Reaven; Debashis Ghosh
Journal:  Ann Epidemiol       Date:  2021-07-17       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.